EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis

Mary-Carty Pittman iD, Alejandro D Perez, Kaniz Afroz Tanni, Keia R Sanderson, Jieun Park iD, Daniel I Feig, Matthew M Laughon, Matthew Shane Loop iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0336994 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS One, 2025. Verfasst von Mary-Carty Pittman und 7 weiteren Autor:innen. Beteiligte Einrichtung: UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, North Carolina, United States of America. Hauptthemen laut MEDLINE: Antihypertensive Agents, Infant, Premature, Hypertension. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Preterm infants are at increased risk for hypertension due to incomplete organ development. With no established guidelines for treating hypertension in this population, clinicians rely on their experience, and little is known regarding those treatment decisions. This study described dosing trajectories for the three most common antihypertensive agents in preterm infants.

Methods

This retrospective, cross-sectional study examined preterm neonates (gestational age at birth < 37 weeks, postmenstrual age < 44 weeks) treated with antihypertensive medications at the University of Alabama at Birmingham (UAB) Medical Center. The study identified the three most common antihypertensive agents and identified common dosing patterns over time using the functional K-means algorithm. We then compared demographic and clinical information across these clusters.

Results

The study included 87 patients across 93 visits. The three most common antihypertensive agents were propranolol (61%), captopril (8.8%), and esmolol (12%). Median treatment durations were 292 hours for propranolol, 186 hours for captopril, and 68 hours for esmolol. Propranolol was often initiated at a dose that was maintained with few dosing changes. Patients needing higher doses of propranolol were generally younger gestational age and spent longer in the hospital. Captopril doses started low and increased over time, likely due to safety concerns. Esmolol showed the most variable dosing trajectories.

Conclusions

Propranolol is often initiated at a target dose and maintained with less titration, while both captopril and esmolol are titrated more often. Younger gestational age patients typically required higher doses of propranolol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsInfant, PrematureHypertensionHumansInfant, NewbornCross-Sectional StudiesRetrospective StudiesFemaleMalePropranololCaptoprilGestational AgePropanolamines

Substanzen

Antihypertensive AgentsPropranololCaptoprilPropanolamines

Autor:innen und Institutionen

  • UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, North Carolina, United States of America.
  • Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Alabama, United States of America.
  • Division of Nephrology and Hypertension, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, North Carolina, United States of America.
  • Harrison College of Pharmacy, Auburn University, Alabama, United States of America.
  • Division of Pediatric Nephrology, Heersink School of Medicine, University of Alabama at Birmingham, Alabama, United States of America.
  • Division of Neonatal-Perinatal Medicine, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, North Carolina, United States of America.

ORCID-Profile: Mary-Carty Pittman, Jieun Park, Matthew Shane Loop

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Pittman, M. C., Perez, A. D., Tanni, K. A., Sanderson, K. R., Park, J., Feig, D. I., Laughon, M. M., & Loop, M. S. (2025). Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis. PLOS One. https://doi.org/10.1371/journal.pone.0336994

Vancouver

Pittman MC, Perez AD, Tanni KA, Sanderson KR, Park J, Feig DI, et al. Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis. PLOS One. 2025. doi:10.1371/journal.pone.0336994

BibTeX
@article{Pittman2025,
  author = {Pittman, Mary-Carty and Perez, Alejandro D and Tanni, Kaniz Afroz and Sanderson, Keia R and Park, Jieun and Feig, Daniel I and Laughon, Matthew M and Loop, Matthew Shane},
  title = {Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0336994}
}
Kostenlos starten →